Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Kliniken Essen-Mitte · University of Duisburg-Essen · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,459
total citations
- FWCI
- 138.15
- Percentile
- 100%
- References
- 35
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Ramucirumab
- Medicine
- Placebo
- Paclitaxel
- Internal medicine
- Clinical endpoint
- Cancer
- Gastroenterology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.